Quantification of spatiotemporal patterns of Ras isoform expression during development
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Ras proteins are important signalling hubs frequently dysregulated in cancer and in a group of developmental disorders called Rasopathies. Three Ras genes encode four proteins that differentially contribute to these phenotypes. Using quantitative real-time PCR (qRT-PCR) we have measured the gene expression profiles of each of the Ras isoforms in a panel of mouse tissues derived from a full developmental time course spanning embryogenesis through to adulthood. In most tissues and developmental stages we observe a relative contribution of KRas4B > > NRas ≥ KRas4A > HRas to total Ras expression with KRas4B typically representing 60–99% of all Ras transcripts. KRas4A is the most dynamically regulated Ras isoform with significant up-regulation of expression observed pre-term in stomach, intestine, kidney and heart. The expression patterns assist interpretation of the essential role of KRas in development and the preponderance of KRas mutations in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
A Comprehensive Survey of Ras Mutations in Cancer
Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063
Self-citationMouse genomic variation and its effect on phenotypes and gene regulation.
Keane, T. M., Goodstadt, L., Danecek, P., White, M. A., Wong, K., Yalcin, B., Heger, A., Agam, A., Slater, G., Goodson, M., et al. (2011) · Nature · doi:10.1038/nature10413 · Cited by 1,580
RAS isoforms and mutations in cancer at a glance
Hobbs, G. A., Der, C. J., & Rossman, K. L. (2016) · Journal of Cell Science · doi:10.1242/jcs.182873 · Cited by 973
Stephen, A. G., Esposito, D., Bagni, R. K., & McCormick, F. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.017 · Cited by 795
Ras and Rap control AMPA receptor trafficking during synaptic plasticity
Zhu, J. J., Qin, Y., Zhao, M., Van Aelst, L., & Malinow, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00897-8 · Cited by 769
Cardiac Myocyte Cell Cycle Control in Development, Disease, and Regeneration
Ahuja, P., Sdek, P., & MacLellan, W. R. (2007) · Physiological Reviews · doi:10.1152/physrev.00032.2006 · Cited by 568
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490
The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine
Harvey, C. D., Yasuda, R., Zhong, H., & Svoboda, K. (2008) · Science · doi:10.1126/science.1159675 · Cited by 434
Komiyama, N. H., Watabe, A. M., Carlisle, H. J., Porter, K., Charlesworth, P., Monti, J., Strathdee, D. J. C., O'Carroll, C. M., Martin, S. J., Morris, R. G. M., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09721.2002 · Cited by 382
Research works printed but not linked: 32
- Aoki, Y., Niihori, T., Inoue, S. & Matsubara, Y. Recent advances in RASopathies. J Hum Genet 61, 33–39, doi: 10.1038/jhg.2015.114 (2016). · DOI · Paper page
- Koera, K. et al. K-ras is essential for the development of the mouse embryo. Oncogene 15, 1151–1159 (1997). · DOI · Paper page
- Esteban, L. M. et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol 21, 1444–1452 (2001). · DOI · Paper page
- Zhao, Z. A. et al. The roles of ERAS during cell lineage specification of mouse early embryonic development. Open Biol 5, doi: 10.1098/rsob.150092 (2015). · DOI
- Kameda, T. & Thomson, J. A. Human ERas gene has an upstream premature polyadenylation signal that results in a truncated, noncoding transcript. Stem Cells 23, 1535–1540, doi: 10.1634/stemcells.2005-0054 (2005). · DOI
- Kaizaki, R. et al. Expression of ERas oncogene in gastric carcinoma. Anticancer Res 29, 2189–2193 (2009).
- Takahashi, K., Mitsui, K. & Yamanaka, S. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423, 541–545, doi: 10.1038/nature01646 (2003). · DOI · Paper page
- Patek, C. E. et al. Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis. Exp Cell Res 314, 1105–1114, doi: 10.1016/j.yexcr.2007.11.004 (2008). · DOI
- Plowman, S. J. et al. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol Cell Biol 23, 9245–9250 (2003). · DOI · Paper page
- Potenza, N. et al. Replacement of K-Ras with H-Ras supports normal embryonic development despite inducing cardiovascular pathology in adult mice. EMBO Rep 6, 432–437 (2005). · DOI
- Leon, J., Guerrero, I. & Pellicer, A. Differential expression of the ras gene family in mice. Mol Cell Biol 7, 1535–1540 (1987). · DOI · Paper page
- Omerovic, J., Hammond, D. E., Clague, M. J. & Prior, I. A. Ras isoform abundance and signalling in human cancer cell lines. Oncogene 27, 2754–2762 (2008). · DOI · Paper page
- Plowman, S. J. et al. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer. Journal of experimental & clinical cancer research: CR 25, 259–267 (2006).
- Tsai, F. D. et al. K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif. Proc Natl Acad Sci USA 112, 779–784, doi: 10.1073/pnas.1412811112 (2015). · DOI · Paper page
- Wang, Y., You, M. & Wang, Y. Alternative splicing of the K-ras gene in mouse tissues and cell lines. Exp Lung Res 27, 255–267 (2001). · DOI
- Muller, R. et al. Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol Cell Biol 3, 1062–1069 (1983). · DOI
- Westermann, A. J., Gorski, S. A. & Vogel, J. Dual RNA-seq of pathogen and host. Nat Rev Microbiol 10, 618–630, doi: 10.1038/nrmicro2852 (2012). · DOI · Paper page
- Ramskold, D. et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol 30, 777–782, doi: 10.1038/nbt.2282 (2012). · DOI · Paper page
- Bender, R. H., Haigis, K. M. & Gutmann, D. H. Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner. Stem Cells 33, 1998–2010, doi: 10.1002/stem.1990 (2015). · DOI
- Jin, S. X., Arai, J., Tian, X., Kumar-Singh, R. & Feig, L. A. Acquisition of contextual discrimination involves the appearance of a RAS-GRF1/p38 mitogen-activated protein (MAP) kinase-mediated signaling pathway that promotes long term potentiation (LTP). J Biol Chem 288, 21703–21713, doi: 10.1074/jbc.M113.471904 (2013). · DOI
- Jin, S. X. & Feig, L. A. Long-term potentiation in the CA1 hippocampus induced by NR2A subunit-containing NMDA glutamate receptors is mediated by Ras-GRF2/Erk map kinase signaling. PLoS One 5, e11732, doi: 10.1371/journal.pone.0011732 (2010). · DOI · Paper page
- Nussinov, R., Tsai, C. J., Chakrabarti, M. & Jang, H. A New View of Ras Isoforms in Cancers. Cancer Res 76, 18–23, doi: 10.1158/0008-5472.CAN-15-1536 (2016). · DOI · Paper page
- Spence, J. R., Lauf, R. & Shroyer, N. F. Vertebrate intestinal endoderm development. Developmental dynamics: an official publication of the American Association of Anatomists 240, 501–520, doi: 10.1002/dvdy.22540 (2011). · DOI · Paper page
- Huels, D. J. & Sansom, O. J. Stem vs non-stem cell origin of colorectal cancer. British journal of cancer 113, 1–5, doi: 10.1038/bjc.2015.214 (2015). · DOI · Paper page
- Bos, J. L. Ras oncogenes in human cancer: a review. Cancer Res 49, 4682–4689 (1989).
- Quinlan, M. P. & Settleman, J. Explaining the preponderance of Kras mutations in human cancer: An isoform-specific function in stem cell expansion. Cell Cycle 7, 1332–1335 (2008). · DOI
- Lampson, B. L. et al. Rare codons regulate KRas oncogenesis. Curr Biol 23, 70–75 (2013). · DOI · Paper page
- Mageean, C. J., Griffiths, J. R., Smith, D. L., Clague, M. J. & Prior, I. A. Absolute Quantification of Endogenous Ras Isoform Abundance. PLoS One 10, e0142674, doi: 10.1371/journal.pone.0142674 (2015). · DOI · Paper page
- Brandmayr, C. et al. Isotope-based analysis of modified tRNA nucleosides correlates modification density with translational efficiency. Angew Chem Int Ed Engl 51, 11162–11165, doi: 10.1002/anie.201203769 (2012). · DOI
- Komar, A. A. The Yin and Yang of Codon Usage. Human molecular genetics, doi: 10.1093/hmg/ddw207 (2016). · DOI · Paper page
- Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J. C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA 90, 8424–8428 (1993). · DOI · Paper page
- Martin, G. R. & Evans, M. J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro . Proc Natl Acad Sci USA 72, 1441–1445 (1975). · DOI · Paper page
Cited by
The Frequency of Ras Mutations in Cancer
Prior, I. A., Hood, F. E., & Hartley, J. L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3682 · Cited by 1,130
Self-citationRAF-MEK-ERK pathway in cancer evolution and treatment
Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.010 · Cited by 553
A model for RAS mutation patterns in cancers: finding the sweet spot
Li, S., Balmain, A., & Counter, C. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0076-6 · Cited by 384
KRAS4A directly regulates hexokinase 1
Amendola, C. R., Mahaffey, J. P., Parker, S. J., Ahearn, I. M., Chen, W.-C., Zhou, M., Court, H., Shi, J., Mendoza, S. L., Morten, M. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1832-9 · Cited by 203
Mo, S. P., Coulson, J. M., & Prior, I. A. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180173 · Cited by 85
Self-citationK-Ras prenylation as a potential anticancer target
Baranyi, M., Buday, L., & Hegedűs, B. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09902-w · Cited by 62
Ras protein abundance correlates with Ras isoform mutation patterns in cancer
Hood, F. E., Sahraoui, Y. M., Jenkins, R. E., & Prior, I. A. (2023) · Oncogene · doi:10.1038/s41388-023-02638-1 · Cited by 56
“Although this means that rare codons are not the mechanistic basis underpinning observed differences in Ras protein dosage, we note that KRAS mRNA levels are disproportionately higher than their relative protein abundance [20].”
InfluentialSelf-citation
Metadata
- Authors
- Newlaczyl, A. U., Coulson, J. M., & Prior, I. A.
- Venue
- Scientific Reports
- Published
- 2017-01-24
- Volume
- 7
- Issue
- 1
- Pages
- 41297-41297
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2580311946
- Cited by
- 58
- References
- 13
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.